224818-27-3

Basic information

• Product Name: 3-(3-PYRROLIDINYLOXY)PYRIDINE
• Synonyms: 3-(3-PYRROLIDINYLOXY)PYRIDINE;3-(PYRROLIDIN-3-YLOXY)-PYRIDINE;3-(3-Pyrrolidinyloxy)pyridine 2HCl
• CAS NO: 224818-27-3
• Molecular Formula: C9H12N2O
• Molecular Weight: 164.20438
• Mol File: 224818-27-3.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-(3-PYRROLIDINYLOXY)PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(3-PYRROLIDINYLOXY)PYRIDINE(224818-27-3)
• EPA Substance Registry System: 3-(3-PYRROLIDINYLOXY)PYRIDINE(224818-27-3)

Safety Data

• Hazardous Substances Data: 224818-27-3(Hazardous Substances Data)

Usage

General Description

3-(3-Pyrrolidinyloxy)pyridine is a chemical compound with the molecular formula C10H12N2O. It is a heterocyclic compound containing a pyridine ring and a pyrrolidine ring. 3-(3-PYRROLIDINYLOXY)PYRIDINE has been identified as a potential ligand for metal ions and has been studied for its potential use in coordination chemistry and metal-organic frameworks. It has also been investigated for its potential use as a building block for the synthesis of organic compounds. Additionally, 3-(3-Pyrrolidinyloxy)pyridine has been studied for its potential biological activities and pharmaceutical applications, making it a versatile and potentially valuable chemical compound.

Upstream product

• 109-00-2 3-HYDROXYPYRIDINE 
• 224818-73-9 (+/-)-3-oxy(3-pyridyl)-1-tert-butoxycarbonylpyrrolidine 

Relevant articles and documents

POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4

Disclosed herein are pyrido[3',2':4,5]thieno[2,3-d]pyridazin-8-amine and thieno[2,3-c:4,5-d']dipyridazin-8-amine compounds, which may be useful as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (mAChR M4).

Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors

A papaverine based pharmacophore model for PDE10A inhibition was generated via SBDD and used to design a library of 4-amino-6,7-dimethoxyquinazolines. From this library emerged an aryl ether pyrrolidyl 6,7-dimethoxyquinazoline series that became the focal

Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application

The present invention provides compounds of the formula: wherein m is 0, 1 or 2; p is 0 or 1; Y is O, S, S(O) or S(O)2 and R1 to R7 are various substituents as selective modulators of the nicotinic acetylcholine receptor u